Al Hummel
Senior Partner
Over 40 years of diverse business and capital markets experience with a history of recognizing valuable business opportunities early on and capitalizing on their intrinsic value, especially in the healthcare market
Prior positions
Chief Executive Officer of Obagi Medical Products
Chief Executive Officer and Director of Cobrek Pharmaceuticals, where he led the company out of near bankruptcy by instituting a system to locate and exploit special market situations within specific drug sectors, leading to shorter drug discovery process and a reduction in drug development time. Cobrek was sold to Perrigo in 2012
Chief Financial Officer of Watson Pharmaceuticals, overseeing the firm IPO and developing its funding strategy. Al sat on the Board for 28 years as well. Watson became Allergan PLC through multiple acquisitions
CEO, President, Co-Founder, and Board Member of Bradley-Hummel & Company, a firm providing investment banking services in the healthcare, energy and financial service industries
Vice President of Merrill Lynch, where he served provided investment banking services to private, corporate, and government (US and foreign) clients
Education
MBA, Indiana University